Anzeige
Mehr »
Login
Freitag, 26.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Wie die Revolution der sauberen Energie eine solide Investitionsmöglichkeit bieten könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
242 Leser
Artikel bewerten:
(1)

Scientific Industries, Inc.: Scientific Industries Announces Medical Industry Veteran as Chief Commercial Officer of Scientific Bioprocessing Inc.

BOHEMIA, NY / ACCESSWIRE / July 21, 2020 / Scientific Industries, Inc. (OTCQB:SCND) announced the appointment of James Buchanan Polk as Chief Commercial Officer of its Scientific Bioprocessing ("SBI") business.

Ms. Helena Santos, CEO of Scientific Industries commented, "As we seek to grow SBI, we needed a strong sales leader. Bucky has the perfect background to help us connect to customers and develop sales channels and OEM accounts. We are excited to add him to our growing team."

Mr. John Moore, Chairman of Scientific Industries and President of SBI stated "I have known Bucky for over thirty years and have watched him progress up the sales ranks and into leadership roles at Boston Scientific, Abbott Labs and Philips Spectranetics where he ultimately held the role of Vice President, Global Key Opinion Leader Engagement. His skill set in market development, product introduction and working with key opinion leaders is ideal to help us build and lead a sales force to turn SBI into a global leader in sensors bioprocessing."

Mr. Polk said, "I am excited to join SBI during this time of growth. It's a unique opportunity to leverage my experience from the Medical Device world and apply it in a natural progression of my career."

About Scientific Industries
Scientific Industries is a life science tool provider. It designs, manufactures, and markets laboratory equipment, including the world-renowned Vortex-Genie® 2 Mixer and balances; customized catalyst research instruments and bioprocessing systems. Scientific Industries' products are generally used and designed for research purposes in laboratories of universities, hospitals, pharmaceutical companies, and medical device manufacturers. Please visit www.scientificindustries.com.

About Scientific Bioprocessing Inc.
Scientific Bioprocessing develops manufactures and sells sensors and instruments for cell culture and bioprocessing. For more information please visit www.scientificbio.com.

"Statements made in this press release that relate to future events, performance or financial results of the Company are forward-looking statements which involve uncertainties that could cause actual events, performance or results to materially differ. The Company undertakes no obligation to update any of these statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as to the date hereof. Accordingly, any forward-looking statement should be read in conjunction with the additional information about risks and uncertainties set forth in the Company's Securities and Exchange Commission reports, including our annual report on Form 10-K."

CONTACT:
Scientific Industries, Inc.
80 Orville Drive, Suite 102
Bohemia, New York 11716
Phone: (888) 850-6208
info@scientificindustries.com
www.scientificindustries.com

SOURCE: Scientific Industries, Inc.



View source version on accesswire.com:
https://www.accesswire.com/598179/Scientific-Industries-Announces-Medical-Industry-Veteran-as-Chief-Commercial-Officer-of-Scientific-Bioprocessing-Inc

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2020 ACCESSWIRE
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.